Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO Registry

By sjmartinez • October 19, 2024

Amubieya O, Todd JL, Neely ML, Kaner RJ, Lasky JA, Namen A, Hesslinger C, Palmer SM, Weigt SS, Belperio JA. Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO Registry. PLoS One. 2024 Oct 17;19(10):e0312044. doi: 10.1371/journal.pone.0312044. PMID: 39418259; PMCID: PMC11486396.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Earlier initiation of tenofovir in pregnancy with infant hepatitis B vaccination obviates the need for hepatitis B immune globulin

Pak K, Saab S. Earlier initiation of tenofovir in pregnancy with infant hepatitis B vaccination obviates the need for hepatitis B immune globulin. Transl Gastroenterol[...]

Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry

Nguyen MD, Fekrat R, Gee C, Demirci AN, Kharabaf S, Le D, Tadros M, Nguyen VQ, Patel S, Truong T, Ahdoot R, Kurtz IB, Kerr[...]

Insurance companies’ lack of LGBTQ+ affirmation: discrimination, distrust, and dissatisfaction among LGBTQ+ people

Nowaskie DZ, Blackwood D, Garcia F, Flautero JD. Insurance companies' lack of LGBTQ+ affirmation: discrimination, distrust, and dissatisfaction among LGBTQ+ people. Front Sociol. 2025 Jul[...]